Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Rational Analyst -- Ignore unavailable to you. Want to Upgrade?

To: HeyRainier who wrote (499)	3/24/1998 10:04:00 AM
From: majormember	Respond to of 1720

Rainier, Thank you for your reply. As you have stated, there are plenty of hypsters who make claims not backed by fact. I am personally loath to that kind of personality. The people on S.I. I do follow and have the most respect for are folks like yourself; and the other pro's who do the real work. As for competition, you will find SNRS to be alone in their treatment for hyperopia. The excimer is being tried to treat hyperopia, but by all accounts, is not nearly as effective as the Yag.holmium laser. I am impressed by the continued strength SNRS price is showing (esp. as I own many shares). Best wishes, Skane

To: HeyRainier who wrote (499)	3/24/1998 10:38:00 AM
From: majormember	Read Replies (1) \| Respond to of 1720

Rainier, This is MUST READ post from SNRS thread: Message 2576202 Also, check today's news. Regards, Skane